Reflow Medical, Inc. announced that the FDA has granted de novo clearance for the company’s Spur peripheral retrievable stent ...

Hyporesponsiveness to erythropoiesis-stimulating agents (ESAs), whether defined as lack of hemoglobin response to typical ESA doses or need for higher ESA doses to reach hemoglobi ...

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...

As the medical device industry transitions to a highly consumer-driven marketplace, incorporating user feedback into new ...

Cyberattackers are well aware of medical device software weaknesses. Are you? RunSafe Security CEO Joe Saunders offers ...

The Food and Drug Administration on Monday is launching an agency-wide generative AI tool aimed at helping scientific ...

The best streaming devices often provide snappier performance and extra perks that your smart TV might be missing. They're also a perfect solution if you want to switch to a different interface or ...

Fidelity Select Medical Tech& Devcs Port earns an Above Average Process Pillar rating. The predominant contributor to the rating is its parent firm's excellent long-term risk-adjusted performance ...

A patient participating in the Phase III MAGNITUDE trial of nex-z experienced asymptomatic grade 4 liver transaminase elevations, the firm reported.

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.